(Total Views: 317)
Posted On: 08/08/2019 6:03:21 AM
Post# of 149053
CytoDyn Files a Phase 2 Protocol with the FDA for Leronlimab (PRO 140) and Regorafenib as a Combination Therapy for Metastatic Colorectal Cancer
http://www.globenewswire.com/news-release/201...ancer.html
http://www.globenewswire.com/news-release/201...ancer.html
(3)
(0)Scroll down for more posts ▼
